Yang, Emily L.
Evers, Patrick D.
Long, Mia J.
Mostafavifar, Mina
Balaji, Seshadri
Article History
Received: 28 June 2023
Accepted: 3 November 2023
First Online: 7 December 2023
Declarations
:
: None of the authors have a relationship with industry-relevant to this manuscript. Seshadri Balaji has a research grant from Medtronic to study sudden cardiac death in hypertrophic cardiomyopathy. Seshadri Balaji is a consultant for Milestone Pharmaceuticals and Alta Thera Pharmaceuticals. The other authors have no disclosures.